Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2025.635 | Development of a risk evaluation model for bone scintigraphy triage based on machine learning and artificial intelligence and large language models. | Dr. Wong Matthew Lun |
| 2025.623 | Can Alpha-ketoglutarate (AKG) Ameliorate Sarcopenia? A Randomized, Double-Blind, Placebo-Controlled Trial | Dr. LIU Chaoran |
| 2025.656 | Unraveling rare and non-SNP genetic variations underlying antipsychotic-induced metabolic side-effects: A comprehensive approach to risk prediction and personalized intervention |
Dr. SO Hon Cheong 蘇漢昌 |
| 2025.649 | Stroke sedentary behaviour Reduction through Identity-based and Temporal-oriented approach (STRIVE): A randomised controlled trial |
Dr. CHENG Ho Yu 鄭可瑜 |
| 2025.672 | Long-term Outcomes and Prognostic Factors in Patients with Acral Atypical Melanocytic Proliferations: A Single Center 21-year Retrospective Cohort Study | Dr. LEE Tin Yan |
| 2025.671 | Hong Kong Cardiogenic Shock Initiative | Dr. So Kent Chak Yu |
| 2025.749 | Comparing diagnostic performance of 3D T1 VIBE MR sequence to CT for the detection of radiographically occult fractures of the hip and pelvis | Dr. CHAN Kwan Kit |
| 2025.634 | A territory-wide retrospective study comparing between transrectal versus transperineal prostate biopsy |
Dr. LIU Alex Qinyang Chi Fai NG |
| 2025.637 | CURE-KD (CUHK-KD score Utility and Regional Evaluation for Kawasaki Disease): Multi-centre validation of the CUHK-KD score for predicting IVIG resistance in paediatric Kawasaki disease | Dr. Cheng Yan Wah |
| 2025.638 | CURE-KD (CUHK-KD score Utility and Regional Evaluation for Kawasaki Disease): Multi-centre validation of the CUHK-KD score for predicting IVIG resistance in paediatric Kawasaki disease | Dr. SO Enoch Chi Tak |
| 2025.624 | Quantitative measurement of plasma and urine MTB cell-free DNA level in diagnosing TB and treatment monitoring | Prof. CHAN Ken Ka Pang |
| 2025.633 | Long-term Outcomes of Prostatic Artery Embolization (PAE) – A retrospective cohort study | Dr. CHIU Peter Ka Fung |
| 2025.611 | AFFIRM: A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis | Prof. Lai Jimmy Che To |
| 2025.632 | The prognostic impact of change in serum alpha-fetoprotein level for recurrent hepatocellular carcinoma after hepatectomy: a retrospective study | Dr. LEE Kit Fai |
| 2025.665 | A Feasibility Trial of a Novel Robotic System for Retrograde Intrarenal Surgery | Prof. NG Chi Fai |
| 2025.620 | A RETROSPECTIVE STUDY ON EFFICACY AND TOLERABILITY OF TRASTUZUMAB DERUXTECAN FOR ADVANCED BREAST CANCER PATIENTS WITH HER2-POSITIVE, HER2-LOW OR HER2-ULTRALOW DISEASE | Prof. YEO Winnie |
| 2025.608 | Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant monotherapy compared with standard of care in patients with early-stage, resectable non-small cell lung cancer (Stage II-IIIB) harboring tyrosine kinase domain activating HER2 mutations | Dr. LOONG Herbert Ho Fung |
| 2025.609 | A prospective randomised study to compare patient satisfaction following the treatment of lower caliceal stones using shockwave lithotripsy or retrograde intrarenal surgery | Prof. NG Chi Fai |
| 2025.655 | The use of Fourier-transformed infrared (FTIR) spectroscopy for the detection of sepsis | Dr. LAU Thomas Yuk Bun |
| 2025.614 | 7-year prospective study of psychiatric patients with comorbid REM sleep behavior disorder: diagnostic stability and progression of prodromal features of α- synucleinopathy | Prof. WING Yun Kwok |
| 2025.603 | Cardio-Oncology in Prostate Cancer: Building a Territory-Wide Cohort with Risk Prediction and Target Trial Emulation framework for cardio-protective strategies | Dr. Liu Qinyang |
| 2025.606 | Natural History of Patients with Staghorn Stones in Hong Kong over 17 years: A Real-World Cross Sectional Observational Study | Dr. LIU Qinyang |
| 2025.685 | Stereotactic Body Radiation Therapy (SBRT) and Radiotherapy Toxicity | Dr. LEUNG Joyce May Sum |
| 2025.662 | A randomized controlled trial: Do blood flow restriction lower limb exercises improve quadriceps muscle strength, pain and functional outcomes in patients with end-stage knee osteoarthritis? | Miss NG Hoi Ying |
| 2025.654 | Effects of GABA with Butyrate, GABA/Butyrate-producing Synbiotics on Pain Relief in Fibromyalgia: a Phase II, Multi-Center, Double-Blinded, Randomized-Controlled Trial (Fibro-Relief Trial) | Prof. CHU Mandy |
| 2025.602 | Dynamic changes of serum albumin-to-globulin ratio predict major adverse cardiovascular events in prostate cancer patients undergoing androgen deprivation therapy | Prof. NG Chi Fai |
| 2025.601 | An international multicenter registry study for young-onset colorectal cancer in East and Southeast Asia | Prof. Ng Simon |
| 2025.600 | Predictive modelling of urological outcomes based on retrospective routine nurse-led clinic assessments | Prof. LIU Qinyang |
| 2025.599 | Erectile dysfunction and major adverse cardiovascular events in prostate cancer | Prof. NG Chi Fai |
| 2025.629 | TulmiSTAR-02: A two-part Phase I dose escalation study of tulmimetostat (DZR123) in combination with darolutamide or abiraterone followed by open-label, randomized, Phase II dose expansion study to assess the safety and efficacy of tulmimetostat in combination with darolutamide versus darolutamide alone in patients with metastatic hormone-sensitive prostate cancer | Prof. NG Chi Fai |
| 2025.613 | Effects of Ten-Week Oral Nicotinamide Riboside Supplementation with Aerobic Exercises on Blood Pressure in Post-menopausal Women with Elevated/Stage I Hypertension | Prof. Yu Angus Pak Hung |
| 2025.615 | Telehealth-supported discharge programme on health outcomes among frail older adults: A pilot randomized controlled trial | Prof. XIAO Sarah |
| 2025.622 | Effect of an internet-based dialectical behaviour therapy-informed skills training for reducing alcohol consumption and improving psychological distress of adult drinkers: A randomised controlled trial | Prof. Ho Long Kwan |
| 2025.657 | A Phase 1/2 Open-label Study to Investigate the Safety, Efficacy, and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Adults and Adolescents with Relapsed or Refractory B cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL) and Minimal Residual Disease Positive (MRD+) B-ALL |
Prof. LI Chi Kong 李志光教授 |
| 2025.621 | Novel microbiome signatures for the prediction of dementia-first versus parkinsonism-first conversion in REM sleep behavior disorder | Dr. HUANG Bei |
| 2025.661 | Unrevealing the multi-level brain reserve against age-related cognitive decline and cardiometabolic risk factors: a three-year follow-up study | Dr. LU Hanna |
| 2025.598 | Epidemiological Trend and Projections on Disease Burden in Hong Kong | Prof. HUANG Junjie |
| 2025.648 | A pilot study on the efficacy and safety of a novel synbiotic formula (SGR11) in patients with inflammatory bowel disease (IBD) | Prof. Ng Siew Chien |
| 2025.597 | Construction of diagnostic and predictive models for cirrhosis patients with complications of liver disease | Prof. Wong Grace |
| 2025.604 | Clamp catheter versus snare for Inferior Vena Cava filter retrieval: a single centre experience | Dr. LAW Wing Chung |
| 2025.588 | Exploring the Protective Role of Bacteroides intestinalis against Metabolic Dysfunction-Associated Steatotic Liver Disease | Prof. ZHANG Xiang |
| 2025.605 | A Phase I/II, Open-label, Multicenter Study of ALE.P03 (Claudin-1 Targeted Antibody-drug Conjugate) as a Monotherapy in Adult Patients with Selected Advanced or Metastatic CLDN1+ Solid Tumors | Prof. CHAN Stephen Lam |
| 2025.616 | The Effects of Transcranial Temporal Interference Stimulation to the Amygdala on Emotion Regulation and Conflict Resolution | Dr. LIU Xiaonan |
| 2025.628 | A Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of GSK5764227 as Monotherapy and in Combination in Participants with Advanced Solid Tumors | Dr. LOONG Herbert Ho Fung |
| 2025.589 | A Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination with Pembrolizumab (MK-3475) Versus Treatment of Physician’s Choice (TPC) in Participants With Triple-Negative Breast Cancer (TNBC) Who Received Neoadjuvant Therapy and Did Not Achieve a Pathological Complete Response (pCR) at Surgery | Prof. YEO Winnie |
| 2025.777 | Speech Disfluency Analysis to Predict Cognitive Impairment --- Developing a Speech Disfluency Framework | Prof. Law Thomas |
| 2025.590 | A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared with Investigator’s Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in Patients with PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05) | Prof. YEO Winnie |
| 2025.596 | Deciphering the role of ADAT2-mediated transfer RNA A-to-I modification in colorectal tumorigenesis and chemoresistance |
Dr. WONG Chi Chun Chi Chun Wong |
| 2025.668 | Knowledge on heart attack and stroke symptoms recognition in Hong Kong residents: a cross-sectional survey |
Mr. WONG Yin Fung 黃然豐 |
| 2025.619 | Review of Clinical Outcomes of Structured Non-Surgical Treatment Programme for Knee Osteoarthritis in Prince of Wales Hospital | Ms. Li Man Kuen |
Page 13 of 285.